Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?

Authors

Danielle Camer, University of WollongongFollow
Xu-Feng Huang, University of WollongongFollow

RIS ID

99697

Publication Details

Camer, D. & Huang, X. (2015). Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?. Journal of Cardiac Failure, 21 (3), 258-259.

Abstract

Letter to the Editor, comment on article entitled "Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl" by Chin et al in the Journal of Cardiac Failure.